TREM2 supports neuronal protection and microglial reactivity without an effect on misfolded protein deposition in chronic neurodegenerative prion disease
IntroductionTriggering receptor expressed on myeloid cells-2 (TREM2) variants have been identified as risk factors for neurodegenerative disease, including Alzheimer’s disease. TREM2 is a cell surface receptor on microglia that regulates homeostatic and immunomodulatory functions, including phagocyt...
Saved in:
| Main Authors: | Sarah M. Carpanini, Barry M. Bradford, Alessio Alfieri, Pedro Piccardo, Jimena Monzón-Sandoval, Deborah Brown, Aileen Boyle, Aleksandra Pokrovskaya, Neil A. Mabbott, Jean Manson, Barry W. McColl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2025.1525017/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism
by: Julia K Götzl, et al.
Published: (2019-05-01) -
Acute LPS exposure enhances susceptibility to peripheral prion infection
by: Reiss Pal, et al.
Published: (2025-03-01) -
Effect of primary structural variation on cervid prion protein in flexibility, stability, and spontaneous misfolding propensity
by: Carlos M. Díaz-Domínguez, et al.
Published: (2025-09-01) -
TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
by: Lianshuai Zhang, et al.
Published: (2025-04-01) -
Roles of prion proteins in mammalian development
by: Yong-Pil Cheon, et al.
Published: (2024-12-01)